CURE compiled the top stories in the lung cancer space, including treatment updates and the potential of cancer vaccines.

Innovent Biologics (OTCPK:IVBIY) announced that Chinese regulators have approved its second marketing application for lung ...

Edgardo S. Santos, MD, FACP, FASCO, discussed the barriers to precision medicine in lung cancer treatment, including patient ...

China National Medical Products Administration (NMPA) has granted acceptance and priority review for the new drug application ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Innovent will receive an $80m upfront payment and could earn up to $1bn in development and commercial milestones.

Identifying lung cancer at its earliest stage before symptoms develop allows for earlier treatment and the potential for cure ...

The FDA approved several drugs in December for the treatment of diseases including pancreatic adenocarcinoma, lung cancer, ...

A new study has identified one of the reasons why cancer frequently spreads from elsewhere in the body to the lungs: an amino ...

The early detection of cancer in patients in Sussex has risen to its highest ever level, according to new NHS analysis. Of ...

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.